EGFR and non-small cell lung carcinoma: Studies have demonstrated that overexpression of EGFR is enhanced cell survival, proliferation, metastasis and angiogenesis in a variety of human malignancies including NSCLC (Yoshida et al., 2010; Seshacharyulu et al., 2012; Kumarakulasinghe et al., 2015).